- IgA Nephropathy Insights
- Posts
- IgA Nephropathy Insights
IgA Nephropathy Insights
This week's must-know community updates, latest research & events
Latest ResearchIgA nephropathy involves the deposition of IgA immune complexes in the kidneys, causing inflammation and potential damage. Symptoms include hematuria, proteinuria, and edema. The disease progresses slowly over years, leading to complications like high blood pressure and chronic kidney disease. Treatment typically involves medications such as ACE inhibitors and ARBs to manage blood pressure and protein loss, along with corticosteroids to reduce inflammation. Lifestyle changes, including diet modifications and smoking cessation, are also recommended. While there is no cure, these interventions can help slow disease progression and prevent complications, as noted in ongoing research into new treatments (Aubron et al., 2025). | ||||||||||||||||
Clinical Trials This is a list of upcoming or ongoing clinical trials that are actively recruiting and have been listed or updated in the last two weeks: Study of ARO-CFB in Adult Healthy Volunteers and Patients With Complement-Mediated Kidney Disease
Evaluation of Efficacy of Povetacicept in Adults With Immunoglobulin A Nephropathy (IgAN)
Study of Ravulizumab in Immunoglobulin A Nephropathy (IgAN)
A Study of SC0062 Capsule for the Treatment of IgA Nephropathy with Proteinuria
| ||||||||||||||||
Upcoming Events | ||||||||||||||||
| ||||||||||||||||